These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22306156)

  • 1. Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles.
    Zhao Q; Allen MJ; Wang Y; Wang B; Wang N; Shi L; Sitrin RD
    Nanomedicine; 2012 Oct; 8(7):1182-9. PubMed ID: 22306156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
    Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
    Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative description of in vitro assembly of human papillomavirus 16 virus-like particles.
    Mukherjee S; Thorsteinsson MV; Johnston LB; DePhillips PA; Zlotnick A
    J Mol Biol; 2008 Aug; 381(1):229-37. PubMed ID: 18585738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).
    Mach H; Volkin DB; Troutman RD; Wang B; Luo Z; Jansen KU; Shi L
    J Pharm Sci; 2006 Oct; 95(10):2195-206. PubMed ID: 16871523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
    Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of intact virus-like particles of human papillomavirus by capillary electrophoresis.
    Bettonville V; Nicol JT; Thelen N; Thiry M; Fillet M; Jacobs N; Servais AC
    Electrophoresis; 2016 Feb; 37(4):579-86. PubMed ID: 26634429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.
    Namvar A; Bolhassani A; Javadi G; Noormohammadi Z
    Sci Rep; 2019 Oct; 9(1):15225. PubMed ID: 31645650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervarix, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions.
    Le Tallec D; Doucet D; Elouahabi A; Harvengt P; Deschuyteneer M; Deschamps M
    Hum Vaccin; 2009 Jul; 5(7):467-74. PubMed ID: 19377291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
    Schädlich L; Senger T; Gerlach B; Mücke N; Klein C; Bravo IG; Müller M; Gissmann L
    J Virol; 2009 Aug; 83(15):7690-705. PubMed ID: 19457985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
    J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
    Jagu S; Karanam B; Gambhira R; Chivukula SV; Chaganti RJ; Lowy DR; Schiller JT; Roden RB
    J Natl Cancer Inst; 2009 Jun; 101(11):782-92. PubMed ID: 19470949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
    Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
    J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
    Eto Y; Saubi N; Ferrer P; Joseph J
    AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.
    Deschuyteneer M; Elouahabi A; Plainchamp D; Plisnier M; Soete D; Corazza Y; Lockman L; Giannini S; Deschamps M
    Hum Vaccin; 2010 May; 6(5):407-19. PubMed ID: 20953154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
    Noris E
    Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.